litlas
ログインアカウント作成

Kun‐Liang Guan

1989–2025 年に発表

303
論文数
115,965
被引用数
167
h 指数
301
i10 指数

被引用数

Kun‐Liang Guan の年別被引用数1983 年: 被引用 2 件1990 年: 被引用 10 件1991 年: 被引用 61 件1992 年: 被引用 96 件1993 年: 被引用 137 件1994 年: 被引用 209 件1995 年: 被引用 278 件1996 年: 被引用 248 件1997 年: 被引用 224 件1998 年: 被引用 266 件1999 年: 被引用 237 件2000 年: 被引用 267 件2001 年: 被引用 302 件2002 年: 被引用 308 件2003 年: 被引用 375 件2004 年: 被引用 479 件2005 年: 被引用 558 件2006 年: 被引用 512 件2007 年: 被引用 532 件2008 年: 被引用 605 件2009 年: 被引用 802 件2010 年: 被引用 916 件2011 年: 被引用 1,179 件2012 年: 被引用 1,324 件2013 年: 被引用 1,409 件2014 年: 被引用 1,682 件2015 年: 被引用 1,909 件2016 年: 被引用 1,924 件2017 年: 被引用 1,869 件2018 年: 被引用 2,067 件2019 年: 被引用 5,224 件2020 年: 被引用 5,860 件2021 年: 被引用 5,597 件2022 年: 被引用 4,487 件2023 年: 被引用 3,252 件2024 年: 被引用 5,000 件2025 年: 被引用 2,312 件2026 年: 被引用 53 件1984〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 13,252 件、この内訳の 29.6%中国: 引用元論文 9,568 件、この内訳の 21.4%イギリス: 引用元論文 2,212 件、この内訳の 4.9%ドイツ: 引用元論文 1,985 件、この内訳の 4.4%日本: 引用元論文 1,547 件、この内訳の 3.5%イタリア: 引用元論文 1,385 件、この内訳の 3.1%カナダ: 引用元論文 1,363 件、この内訳の 3.1%フランス: 引用元論文 1,289 件、この内訳の 2.9%韓国: 引用元論文 1,058 件、この内訳の 2.4%スペイン: 引用元論文 820 件、この内訳の 1.8%オーストラリア: 引用元論文 818 件、この内訳の 1.8%スイス: 引用元論文 725 件、この内訳の 1.6%
0%29.6%その他 19.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology53.5%
  • Medicine35.6%
  • Immunology and Microbiology3.9%
  • Neuroscience3.5%
  • Agricultural and Biological Sciences1.1%
  • Engineering0.5%
  • その他1.9%

トピック

  • Autophagy in Disease and Therapy5.4%
  • Hippo pathway signaling and YAP/TAZ4.8%
  • Cancer, Hypoxia, and Metabolism2.8%
  • PI3K/AKT/mTOR signaling in cancer2.7%
  • Epigenetics and DNA Methylation2.2%
  • Metabolism, Diabetes, and Cancer1.9%
  • その他80.2%

共著者

全論文

検索で開く
  1. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

    著者: Joungmok Kim, Mondira Kundu, Benoı̂t Viollet, Kun‐Liang Guan - Nature Cell Biology 2011 被引用: 7,048

  2. mTOR: a pharmacologic target for autophagy regulation

    著者: Young Chul Kim, Kun‐Liang Guan - Journal of Clinical Investigation 2015 被引用: 2,132

  3. The Hippo Pathway: Biology and Pathophysiology

    著者: Shenghong Ma, Zhipeng Meng, Rui Chen, Kun‐Liang Guan - Annual Review of Biochemistry 2018 被引用: 1,441

  4. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

    著者: Bin Zhao, Xiaomu Wei, Weiquan Li, Ryan S. Udan, Qian Yang, Joungmok Kim, Joe Xie, Tsuneo Ikenoue, Jindan Yu, Li Li, Pan Zheng, Keqiang Ye, Arul M. Chinnaiyan, Georg Halder, Zhi-Chun Lai, Kun‐Liang Guan - Genes & Development 2007 被引用: 3,151

  5. The Hippo signalling pathway and its implications in human health and diseases

    著者: Minyang Fu, Yuan Hu, Tianxia Lan, Kun‐Liang Guan, Ting Luo, Min Luo - Signal Transduction and Targeted Therapy 2022 被引用: 694

  6. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

    著者: Anwesha Dey, Xaralabos Varelas, Kun‐Liang Guan - Nature Reviews Drug Discovery 2020 被引用: 879

  7. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

    著者: Fa‐Xing Yu, Bin Zhao, Kun‐Liang Guan - Cell 2015 被引用: 2,286

  8. Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

    著者: Wei Xu, Hui Yang, Ying Liu, Ying Yang, Ping Wang, Se Hee Kim, Shinsuke Ito, Yang Chen, Pu Wang, Meng-Tao Xiao, Li-xia Liu, Wen-qing Jiang, Jing Liu, Jin-ye Zhang, Bin Wang, Stephen V. Frye, Yi Zhang, Yan-hui Xu, Qun‐Ying Lei, Kun‐Liang Guan, Shimin Zhao, Yue Xiong - Cancer Cell 2011 被引用: 2,849

  9. TEAD mediates YAP-dependent gene induction and growth control

    著者: Bin Zhao, Xin Ye, Jindan Yu, Li Li, Weiquan Li, Siming Li, Jianjun Yu, Jiandie D. Lin, Cun-Yu Wang, Arul M. Chinnaiyan, Zhi-Chun Lai, Kun‐Liang Guan - Genes & Development 2008 被引用: 2,524

  10. Mechanisms of Hippo pathway regulation

    著者: Zhipeng Meng, Toshiro Moroishi, Kun‐Liang Guan - Genes & Development 2016 被引用: 1,729

  11. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival

    著者: Ken Inoki, Tianqing Zhu, Kun‐Liang Guan - Cell 2003 被引用: 3,913

  12. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP

    著者: Bin Zhao, Li Li, Karen Tumaneng, Cun‐Yu Wang, Kun‐Liang Guan - Genes & Development 2010 被引用: 1,441

  13. mTOR as a central hub of nutrient signalling and cell growth

    著者: Joungmok Kim, Kun‐Liang Guan - Nature Cell Biology 2018 被引用: 1,098

  14. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase

    著者: Ryan C. Russell, Ye Tian, Hai‐Xin Yuan, Hyun Woo Park, Yu-Yun Chang, Joungmok Kim, Haerin Kim, Thomas P. Neufeld, Andrew Dillin, Kun‐Liang Guan - Nature Cell Biology 2013 被引用: 1,534

  15. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

    著者: Mengtao Xiao, Hui Yang, Wei Xu, Shenghong Ma, Huaipeng Lin, Honguang Zhu, Lixia Liu, Ying Liu, Yang Chen, Yanhui Xu, Shimin Zhao, Dan Ye, Yue Xiong, Kun‐Liang Guan - Genes & Development 2012 被引用: 1,132

  16. Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

    著者: Fa‐Xing Yu, Bin Zhao, Nattapon Panupinthu, Jenna L. Jewell, Ian Lian, Lloyd H. Wang, Jiagang Zhao, Hai‐Xin Yuan, Karen Tumaneng, Hairi Li, Xiangdong Fu, Gordon B. Mills, Kun‐Liang Guan - Cell 2012 被引用: 1,667

  17. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

    著者: Ken Inoki, Yong Li, Tianquan Zhu, Jun Wu, Kun‐Liang Guan - Nature Cell Biology 2002 被引用: 3,056

  18. Insights into recent findings and clinical application of YAP and TAZ in cancer

    著者: James Franklin, ZhengMing Wu, Kun‐Liang Guan - Nature reviews. Cancer 2023 被引用: 209

  19. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity

    著者: Zhu Huang, Robert Blum, Davide Bernareggi, Eivind Heggernes Ask, ZhengMing Wu, Hanna Julie Hoel, Zhipeng Meng, Chengsheng Wu, Kun‐Liang Guan, Karl‐Johan Malmberg, Dan S. Kaufman - Cell stem cell 2020 被引用: 334

  20. Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity

    著者: Xiaoya Li, Tianxiang Wang, Xinmei Huang, Yue Li, Tiange Sun, Shufei Zang, Kun‐Liang Guan, Yue Xiong, Jun Liu, Hai‐Xin Yuan - Liver International 2020 被引用: 277

  21. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy

    著者: Yujia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Minjie Fu, Zhou‐Li Cheng, Zhen Yang, Gui‐Qi Zhu, Xudong Wang, Cheng Zhang, Jinye Zhang, Yiping Sun, Hexige Saiyin, Jin Zhang, Wei‐Ren Liu, Wenwei Zhu, Kun‐Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Leilei Chen - Science Advances 2023 被引用: 143

  22. Interplay between YAP/TAZ and Metabolism

    著者: Ja Hyun Koo, Kun‐Liang Guan - Cell Metabolism 2018 被引用: 498

  23. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses

    著者: Leilei Chen, Carmen Morcelle, Zhou‐Li Cheng, Xiufei Chen, Yanping Xu, Yajing Gao, Junbin Song, Zhijun Li, Matthew D. Smith, Miao Shi, Yezhang Zhu, Neng Zhou, Meng Cheng, Chenxi He, Kwei‐Yan Liu, Guoping Lü, Lei Zhang, Cheng Zhang, Jinye Zhang, Yiping Sun, Tuan Qi, Yingying Lyu, Zhizhong Ren, Xianming Tan, Jiayong Yin, Fei Lan, Ying Liu, Hui Yang, Maoxiang Qian, Cai‐Wen Duan, Xing Chang, Yufeng Zhou, Li Shen, Albert S. Baldwin, Kun‐Liang Guan, Yue Xiong, Dan Ye - Nature Cell Biology 2022 被引用: 206

  24. The emerging roles of YAP and TAZ in cancer

    著者: Toshiro Moroishi, Carsten Gram Hansen, Kun‐Liang Guan - Nature reviews. Cancer 2015 被引用: 1,183